
NAD+ and Epitalon: The Longevity Stack
From Today's discussion by Infinity Peptides
June 15, 2026 · 22 min · Season 2 · Episode 4
About this episode
The episode discusses the combination of NAD+ and Epitalon as a potential longevity stack, highlighting the gap between anecdotal evidence and clinical research.
Let's examine the popular biohacking combination of NAD+ and Epitalon , a pairing often referred to as a cellular rejuvenation stack . While NAD+ is essential for mitochondrial energy and DNA repair, Epitalon is a synthetic peptide theorized to influence telomere length and circadian rhythms. The analysis highlights a significant gap between the enthusiastic anecdotal reports from the longevity community and the actual clinical evidence , which remains limited or inconsistent in humans. Proponents suggest that combining these substances targets aging from two angles by simultaneously supporting metabolic power and genomic stability . Ultimately, the source concludes that while the biological theories behind this stack are compelling, long-term human trials are necessary to validate claims of anti-aging and life extension.
People in this episode
Host: Infinity Peptides
Topics covered
- biohacking
- longevity
- cellular rejuvenation
- metabolic power
- genomic stability
- anti-aging
- clinical evidence
Keywords
- NAD+
- Epitalon
- longevity
- biohacking
- cellular rejuvenation
- anti-aging
- clinical evidence
Mentioned in this episode
Organizations: longevity community
Products: NAD+, Epitalon
More episodes of Today's discussion
- Pinealon: The Science and Hype of Brain Bioregulators · September 8, 2026 · 21 min
- Dulaglutide: The Foundation of Modern Metabolic Medicine · August 31, 2026 · 21 min
- FOXO4-DRI: The Science and Hype of Senolytic Peptides · August 24, 2026 · 26 min
- Cerebrolysin: Clinical Science and Biohacking Analysis · August 17, 2026 · 23 min
- ADAMAX Peptide: Science, Hype, and Cognitive Potential · August 10, 2026 · 19 min
- Survodutide: The Metabolic Power of Dual Receptor Agonism · August 3, 2026 · 20 min
Explore listener stats, chart rankings, contacts and more on the Today's discussion podcast page.